Integrated Supportive and Palliative Care for Critical Illness
(ProPACC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if integrating palliative care early with standard critical care can improve outcomes for critically ill older patients and reduce stress for their families. Palliative care prioritizes comfort and quality of life rather than solely extending life. The trial includes two groups: one receiving early palliative care alongside usual ICU care, and another receiving only standard ICU care. Suitable participants have recently been in the ICU with serious health issues, such as advanced cancer or severe organ failure, or have shown significant health decline. As an unphased trial, this study provides a unique opportunity to contribute to understanding how early palliative care can enhance patient and family experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this protocol is safe for critically ill older patients?
Research shows that combining palliative care with critical care is generally well-received by patients. Studies have found that this approach reduces discomfort, meaning patients feel less pain and distress. It also improves communication between doctors and patients about treatment goals, ensuring that care aligns with patient preferences.
Evidence from heart intensive care units suggests that early palliative care positively affects patient outcomes. This includes enhancing the effectiveness of ICU care and possibly improving the overall experience for both patients and their families.
In short, studies indicate that early palliative care in critical care is safe and beneficial for patients.12345Why are researchers excited about this trial?
Researchers are excited about the early integration of specialty palliative care with critical care because it aims to blend compassionate support with intensive medical treatment right from the start of a critical illness. Unlike standard ICU care, which typically involves family meetings after admission, this approach actively involves palliative care specialists early on to address not just physical symptoms but also emotional and psychological needs. This integrated method could potentially improve patient outcomes and family satisfaction, leading to a more holistic and supportive experience during critical illness.
What evidence suggests that early integration of specialty palliative care with critical care is effective for critically ill older patients?
This trial will compare the early integration of specialty palliative care with standard critical care to usual ICU care. Research has shown that starting palliative care early alongside critical care in the ICU can greatly benefit patients. Studies have found that this approach eases symptoms and aligns treatments with patient preferences. It also reduces stress for family members and improves communication about care goals. Palliative care plays a crucial role in managing symptoms and providing emotional support, often needed in intensive care. Overall, combining palliative care with critical care leads to better outcomes for seriously ill patients and their families.13678
Who Is on the Research Team?
Douglas B White, MD, MAS
Principal Investigator
University of Pittsburgh
Yael Schenker, MD, MAS
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for older adults (60+) in the ICU with critical illnesses like coma after cardiac arrest, severe strokes, organ failures, or chronic conditions such as end-stage liver disease. They must have a high risk of death or severe disability and not be imminently dying, within a year post-organ transplant, non-English speaking, or without a surrogate decision maker.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Early integration of specialty palliative care with standard critical care for critically ill older patients
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Assessment of resource utilization and survival from hospital discharge through 6-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Early Integration of Specialty Palliative Care with Critical Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Massachusetts General Hospital
Collaborator
National Institute on Aging (NIA)
Collaborator